Comparing wound healing methods in breast reduction surgery
Official title: Assessing the Application of Closed Incision Negative Pressure Wound Therapy to Reduction Mammaplasty
Run by Medstar Health Research Institute · NCT06725459 · Data updated 2026-11-12
This study is testing if a special type of wound treatment helps women heal better after breast reduction surgery compared to regular bandages.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 92 (estimated) |
| Sponsor | Medstar Health Research Institute Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Status | Recruiting |
| Started | December 17, 2024 |
| Main results expected | July 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | October 27, 2025 |
| Trial ID | NCT06725459 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are female patients aged 18 years or older scheduled for bilateral reduction mammaplasty with specific incision patterns.
✕Probably not a fit
Patients who are biologically male, younger than 18, or have a history of breast cancer or other significant medical conditions affecting wound healing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of prophylactic closed incision negative pressure wound therapy (ciNPWT) compared to standard adhesive dressing in female patients undergoing bilateral reduction mammaplasty. It is a prospective, randomized, split-body control trial that will assess complications, patient-reported outcomes, and cost differentials associated with each method. Participants will be monitored for their recovery and satisfaction following the surgical procedure. The study is being conducted at MedStar Georgetown University Hospital and MedStar Good Samaritan Hospital.
Why it matters
Potential benefit: If successful, this study could lead to improved wound healing and reduced complications for patients undergoing breast reduction surgery.
How similar studies have gone: Other studies have shown promising results with negative pressure wound therapy in various surgical settings, suggesting potential benefits in this context as well.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients * Age 18 years or older * Scheduled to undergo bilateral reduction mammaplasty with a Wise pattern (anchor) incision and a superomedial, inferior, or central mound pedicle at MedStar Georgetown University Hospital or MedStar Good Samaritan Hospital * Able to comply with study procedures and follow-up visits Exclusion Criteria: * Younger than 18 years of age * Biologically male patients * Scheduled to undergo unilateral breast mammaplasty * Currently pregnant or lactating * Use of steroids or other immune modulators known to affect wound healing * Current smokers who have not paused for a minimum of 4 weeks prior to surgery * History of breast cancer * History of oncologic or reconstructive breast surgery * History of radiation to the breast * History of chemotherapy or hormone therapy * Tattoos in the area of skin incision * Skin conditions known to affect wound healing or scarring of the breast (e.g., cutis laxa) * Significant history of scar problems (e.g., hypertrophic scarring or keloids) post-surgical incisions with active bleeding * Exposure of blood vessels, organs, bone, or tendon at the base of the reference wound * Known allergies to product components (e.g., medical or NPWT tape) * Unable to comply with NPWT requirements, including those unable to present for postoperative follow-up * Lactating at the time of surgery * Require deviation from standard operative or closure techniques (e.g., staples, free nipple grafts) * Considered part of a vulnerable population (adults unable to consent, infants, children, teenagers, pregnant women, prisoners) * Experience intraoperative complications due to surgical complications not related to the NPWT instrumentation (e.g., expanding hematoma)
Where it's running
-
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States Recruiting
Study contacts
- Principal investigator: Kenneth L Fan, MD — MedStar Georgetown University Hospital
- Study coordinator: Ryan P Lin, MD
- Email: Ryan.Lin@medstar.net
- Phone: 2407787804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lactoferrin Gel for Healing and Implant Stability in Immediate Mandibular Molars
A 4% bovine lactoferrin nanohydrogel is being tested to see if it helps soft tissue and bone heal better and improve implant stability after immediate mandibular molar implants.
-
Curcumin topical spray for healing after a first molar extraction
This study tests whether a curcumin spray applied to the extraction site helps healing and reduces pain compared with chlorhexidine spray or standard care in healthy adults undergoing a first molar extraction.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
Obesity and normal-weight healing after gum graft surgery using collagen plug or PRF
This study tests whether healing after a gum graft differs by weight class (obese vs. normal weight) and compares platelet-rich fibrin clot to the standard collagen plug.
-
Early Wound Healing and Outcomes of Regenerative Periodontal Surgery
This study looks to see if healing in the first 1–2 weeks after periodontal regenerative surgery can predict how well the treatment works at 12 months in people with advanced periodontitis.
-
Ozoaqua scar care after open abdominal surgery compared with standard care
This study tests if adding Ozoaqua products after open abdominal surgery improves the scar quality at 3 months compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.